So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡

Researchers at MD Anderson are leading the way with studies like the Diet and Immune Effects Trial (DIET), which explores how diet may impact response to cancer treatment. New results from this important study will be shared at #ASCO25. Learn more: http://spr.ly/63324N2YtA#ASCO25#EndCancer

In advance of #ASCO25, @cmannunziata.bsky.social told me, “We are worried that the cuts to the NIH will drastically impact our ability to do research, to find these new molecular mechanisms of cancer and develop new cures. If we don't have the funding to do the research, this will not happen.”

#ASCO25: Artificial Intelligence assistance can help improve accuracy in identifying HER2-Low and HER2-Ultralow breast cancers, avoid misclassification www.saluteh24.com/il_weblog_di...

Join us for the Final Quackdown practice picket, march, and rally on Friday, March 14th, from 11:30 a.m. to 1 p.m., starting at the Ford Alumni Center. A massive turnout sends a powerful message—drop everything and be there!

Look for UA in today's Eugene Weekly. There is an article on page five and this beauty!

This could mean we patients won’t get the next breakthrough treatment.

🗃️ CFP for a special issue of The Public Historian.

That’s the same basic idea behind the current system of indirect cost rates for universities. A university has buildings with labs and furniture and electricity and IT systems (and on and on). They don’t need to buy those things all over again each time a new research study is funded. 7/

Five.

From @aaup.bsky.social, what to do if ICE is on your campus.

I’m trying to figure out where all my cancer meds are manufactured tonight while worrying about access and shortages. It sure is a fun time to have cancer!

Let’s try something. We here at @altnih4science.bsky.social want to boost descriptions of NIH-funded science. If you’re a scientist with a post or thread that describes your work, please tag us or DM us, and we’ll repost. We’ll use the #NIHFundsGreatScience hashtag so people can read in future. 🧪

Follow this link to find out how to advocate for MBC patients in light of the recent directive to halt external communications from the Department of Health and Human Services (HHS).

NEW: My staff has confirmed reports that Medicaid portals are down in all 50 states following last night's federal funding freeze. This is a blatant attempt to rip away health care from millions of Americans overnight and will get people killed.

Formerly incarcerated firefighter Eddie Herrera just wants people to treat incarcerated firefighters like human beings.

random sampling of 100 major grant-in-aid programs in no particular order and with no particular selection rule.

#Eugenics on a global scale

Who knew “and then they came for the cancer patients” was gonna be so high up in the poem?

Does anyone have advice on how to write a strong appeals letter? My insurance company won’t cover the medications keeping my liver, brain, and bone mets (from breast cancer) stable. I feel like my life is riding on this appeal…because it kinda is. #bcsm #cancer

I was set to enter a clinical trial in February. It's since been canceled. You are spot on with "cancer itself will not agree to such a delay." #Cansky

Most folks do not understand how far in advance the planning and logistics of NIH grants take. We prepare for months or years for these submissions for one of 3 cycles per year. This study section cancellation delays grants by at least 6 months when study sections are cancelled.

Today a reporter reached out to me after seeing posts I made on Bluesky about what’s going on at NIH. Keep typing, keep talking, keep shouting, because your voice goes beyond the void.

I know there’s a lot happening, but this is critical: Study sections at the NIH have been shut down. ➡️ No reviews = No grants ➡️ No grants = No research ➡️ No research = No NIH This threatens the future of science & medicine. #MedSky #HealthPolicy #NIH

Oncology starter pack volume 1 (all cancer types). go.bsky.app/GKXp9Fy Scroll up for more including the #ASCO #GI25 starter pack I created specifically for 🚨🧪GI cancer research coverage🧪🚨. Have a favorite abstract? Post a link and ask to join! Don't forget the🧪!

The landmark 1994 Executive Order on Environmental Justice is among those rescinded. www.eenews.net/articles/tru...

If you're a researcher impacted by the NIH/CDC/FDA travel and communication pause and are open to chatting about your experience, big or small, please reach out to me at [email protected] or DM for Signal

Let's do this!

Similar thing here. My wife is working on registration of a new anti-cancer drug. Received info today that FDA activities have been halted, registration process suspended for an unspecified period… 🤪

The number of people in my life who are at this very moment currently fighting with health insurance companies over procedures and medications they need is so infuriating. Our whole country's approach to healthcare in every way is absolutely terrible. The whole system needs to be trashed.

Waiting to find out if the insurance company will cover the first treatment in over a year that has fully stabilized the cancer is terrifying. #ThisIsMBC #bcsm

Advocacy makes a difference 🎉 A week ago I shared w/ Dr. Alistair Thompson that "right-sizing treatment" is preferred terminology to "de-escalation." Latter can imply 'less than" which, in absence of strong health/disease literacy, can be terrifying. Today he shared that info his #SABCS24 preso

#sabcs24 #cancer

To build on the progress shared at #SABCS24 for triple-positive MBC ( #PATINA), when treatments stop working, is it the HER2 or HR component driving resistance? Need a biomarker! Patients want the most mileage from every treatment! PS: Finally, +++ is being treated differently from HER2+/HR–.

@bsky.app more than adequately picked up what was lost from Twitter when it comes to medical conferences. #sabcs24 was a throwback to those old days of following posts, seeing different perspectives on data, and seeing colleagues in San Antonio. #hcsm has a new home. #oncsm #oncsky

Wrapping up another fantastic #SABCS! Amazing, practice-changing data were presented. I’ve updated the algorithms and added key studies from the meeting— I finally ran out of space in HR+ disease! #SABCS24 @oncoalert.bsky.social

The poster spotlight on brain mets this am is fantastic and so exciting/hopeful for better options for treatments to come across subtypes. #SABCS24

#SABCS24 #bcsm #OncSky #MedSky Finally, if you have Qs about #compassionateuse of investigational agents (not only for #cancer) because you can’t access #clinicaltrials, the Regan-Udall Expanded Access Navigator is a huge help! Check it out! navigator.reaganudall.org @oncoalert.bsky.social

“Cancer patients are your biggest supporters b/c our lives depend on your success.” - patient advocate Christine Hodgdon #SABCS24

Congratulations to BCRF investigator Dr. Steffi Oesterreich for receiving this year’s AACR (@theaacr.bsky.social) Distinguished Lectureship in Breast Cancer Research Award at #SABCS24. She has made groundbreaking contributions in translational breast cancer research. @sabcs.bsky.social

Age is an independent predictor of brain mets across all bc subtypes (yes, even er+\her2-). Younger women are at higher risk. Dr. Diana Cittelly’s fascinating discussion of estrogen and brain mets went well beyond this but as someone diagnosed under 40 with MBC, I wish I knew this earlier. #SABCS24

Today’s Alamo Breast Cancer Foundation session today starts out honoring one of the greatest advocates I’ve ever known, a good friend, a clinical trial hero Sheila Johnson. May she rest in power. #SABCS24

Dr Davis gave an inspiring talk this morning, phenomenal re what's possible in parallel multi-omic approaches to understanding biological vs social drivers of cancer health disparities. #SABCS24

‼️When you thought you had the #SABCS24 program figured out, here’s the PRACTICE-CHANGING #PATINA trial being added! For the impatient ones, press release here: www.businesswire.com/news/home/20... If you’re in San Anyonio, though, make sure to attend the data presentation today by Otto Metzger!

Amazing talk by Melissa Davis - absolute tour de force on how she & her group have done “Unraveling Social vs Biological Drivers of Racial Disparities in Cancer Outcomes” #SABCS24

Wow! Dr. Davis’s presentation was incredible. Dr. Davis concluded with an Environmental Justice frame that will enhance the future of precision medicine. #SABCS24

Dr. Melissa Davis highlights that discordant survival in breast cancer by race is more than socioeconomic variables during @sabcs.bsky.social Plenary Session #SABCS24

Hope S. Rugo, MD, FASCO, discusses updated safety findings from the ELEVATE trial of elacestrant-based combinations in ER+/HER2– metastatic breast cancer. @hoperugo.bsky.social @ucsfcancer.bsky.social @sabcs.bsky.social #SABCS24 #bcsm #oncology www.onclive.com/view/dr-rugo...